Publicaciones en colaboración con investigadores/as de Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (22)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Corrigendum to “Dissecting the genetic heterogeneity of gastric cancer” (eBioMedicine (2023) 92, (S2352396423001810), (10.1016/j.ebiom.2023.104616))

    eBioMedicine

  3. Dissecting the genetic heterogeneity of gastric cancer

    eBioMedicine, Vol. 92

2022

  1. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

2021

  1. Spread of a SARS-CoV-2 variant through Europe in the summer of 2020

    Nature, Vol. 595, Núm. 7869, pp. 707-712

  2. The first wave of the COVID-19 epidemic in Spain was associated with early introductions and fast spread of a dominating genetic variant

    Nature Genetics, Vol. 53, Núm. 10, pp. 1405-1414

2016

  1. Comparison of body mass index (BMI) with the CUN-BAE body adiposity estimator in the prediction of hypertension and type 2 diabetes

    BMC Public Health, Vol. 16, Núm. 1

  2. High Body Mass Index as a Risk Factor for Hospitalization Due to Influenza: A Case-Control Study

    Archivos de Bronconeumologia, Vol. 52, Núm. 6, pp. 299-307

  3. Smoking may increase the risk of hospitalization due to influenza

    European Journal of Public Health, Vol. 26, Núm. 5, pp. 882-887

2014

  1. Pandemic influenza A (H1N1) in non-vaccinated, pregnant women in Spain (2009-2010)

    Maternal and Child Health Journal, Vol. 18, Núm. 6, pp. 1454-1461

2013

  1. Benefit of conjugate pneumococcal vaccination in preventing influenza hospitalization in children: A case-control study

    Pediatric Infectious Disease Journal, Vol. 32, Núm. 4, pp. 330-334

  2. Different prognosis in hospitalized patients with influenza one season after the pandemic H1N1 influenza of 2009-2010 in Spain

    Influenza and other Respiratory Viruses, Vol. 7, Núm. 6, pp. 1336-1342

  3. Effectiveness of vaccination with 23-valent pneumococcal polysaccharide vaccine in preventing hospitalization with laboratory confirmed influenza during the 2009-2010 and 2010-2011 seasons

    Human Vaccines and Immunotherapeutics, Vol. 9, Núm. 4, pp. 865-873

  4. Influenza vaccine effectiveness in preventing outpatient, inpatient, and severe cases of laboratory-confirmed influenza

    Clinical Infectious Diseases, Vol. 57, Núm. 2, pp. 167-175

  5. Risk factors and effectiveness of preventive measures against influenza in the community

    Influenza and other Respiratory Viruses, Vol. 7, Núm. 2, pp. 177-183

  6. Social factors related to the clinical severity of influenza cases in Spain during the A (H1N1) 2009 virus pandemic

    BMC Public Health, Vol. 13, Núm. 1

2012

  1. Effectiveness of hand hygiene and provision of information in preventing influenza cases requiring hospitalization

    Preventive Medicine, Vol. 54, Núm. 6, pp. 434-439

  2. Effectiveness of pandemic and seasonal influenza vaccines in preventing pandemic influenza-associated hospitalization

    Vaccine, Vol. 30, Núm. 38, pp. 5644-5650

  3. Prognosis of hospitalized patients with 2009 H1N1 influenza in Spain: Influence of neuraminidase inhibitors

    Journal of Antimicrobial Chemotherapy, Vol. 67, Núm. 7, pp. 1739-1745

  4. Score to identify the severity of adult patients with influenza A (H1N1) 2009 virus infection at hospital admission

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 31, Núm. 10, pp. 2693-2701